Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a report issued on Friday morning. The firm issued a buy rating on the health services provider’s stock. A number of other equities analysts have also commented on the stock. Cantor Fitzgerald increased their price target on shares of Amedisys from $100.00 to […]
Amedisys, Inc. (NASDAQ:AMED – Get Free Report) has earned a consensus recommendation of “Hold” from the eleven analysts that are presently covering the firm, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that […]
USPI saw "midteens" growth in total joint replacements at its ASCs in the third quarter of 2022. This growth was driven by the addition of 6 centers focused on
Quantinno Capital Management LP bought a new position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 15,326 shares of the health services provider’s stock, valued at approximately $1,401,000. Other large investors have also […]
State of New Jersey Common Pension Fund D lifted its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 23.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,553 shares of the health services provider’s stock after purchasing […]